AIM
MNOV icon

Acrospire Investment Management’s MediciNova MNOV Stock Holding History

Acrospire Investment Management’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,923
Closed -$10K – 880
2017
Q2 		$10K Buy
+1,923
New +$10.8K 0.01% 1799
2017
Q1 		– Sell
-7,658
Closed -$46K – 2385
2016
Q4 		$46K Sell
7,658
-3,200
-29% -$22.5K 0.02% 1448
2016
Q3 		$81K Buy
10,858
+1,530
+16% +$10.3K 0.05% 713
2016
Q2 		$70K Buy
9,328
+1,800
+24% +$13K 0.05% 791
2016
Q1 		$55K Buy
+7,528
New +$37.3K 0.04% 849

Other funds holding MNOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Acrospire Investment Management's MNOV Position: Q3 2017 in Review

Acrospire Investment Management sold out of MediciNova (MNOV) in Q3 2017, closing a stake of 1,923 shares — an estimated $10K sold.

Acrospire Investment Management first reported a position in MNOV in Q1 2016 and held it in 5 quarters. The position peaked at $81K in Q3 2016. 47 funds tracked by Wall St. Rank hold MNOV as of Q3 2017.

  • Acrospire Investment Management reported no remaining MediciNova position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,923 MediciNova shares in Q3 2017, an estimated $10K.
  • Acrospire Investment Management first reported a position in MediciNova in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's MediciNova position peaked at $81K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held MediciNova as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.